Efficacy of early treatment with infliximab in pediatric Crohn's disease. - Wikidata - awgldk - TriplyDB

Efficacy of early treatment with infliximab in pediatric Crohn's disease.

Efficacy of early treatment with infliximab in pediatric Crohn's disease.

http://www.wikidata.org/entity/Q33782089

about

Association between Genetic Polymorphisms and Response to Anti-TNFs in Patients with Inflammatory Bowel Disease Change in the treatment strategy for pediatric Crohn's disease Efficacy of Early Infliximab Treatment for Pediatric Crohn's Disease: A Three-year Follow-up.Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease Antitumor necrosis factor treatment for pediatric inflammatory bowel disease.Advances in the medical management of paediatric IBD.Adalimumab for the treatment of pediatric Crohn's disease.Top-down Infliximab Study in Kids with Crohn's disease (TISKids): an international multicentre randomised controlled trial.Typical gastroduodenal endoscopic findings in a Crohn's disease patient in remission stage Is top-down therapy a more effective alternative to conventional step-up therapy for Crohn’s disease?

P2860

Q26767247-6A7B4A1D-D85E-44ED-B44F-9894B58F43C0 Q34420755-DBCEB3C0-7039-484B-8B4D-FB9CC04DF388 Q37101534-7C577424-F434-466E-B88F-373768744F48 Q37609746-7C448CB8-EFE7-4779-8771-E0DE76669D7A Q37936394-8EEF9526-6A2C-4E08-A517-67C1C5378F5B Q38130044-A65EAF48-3A37-4155-AC9D-593EACAB6CF5 Q38554433-81030DDD-050F-481C-9F94-CC69D7D7D8D4 Q41111300-EEAAABE2-837D-49AE-992F-5F4B599D28CC Q41971917-D336D4D3-D5C7-4C21-B3D1-CEE20A6F3E16 Q55505680-7F7D4144-B86B-4A6B-A941-1797B5391609

P2860

Efficacy of early treatment with infliximab in pediatric Crohn's disease.

http://www.wikidata.org/entity/Q33782089

description

2010 nî lūn-bûn

@nan

2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Efficacy of early treatment with infliximab in pediatric Crohn's disease.

@ast

Efficacy of early treatment with infliximab in pediatric Crohn's disease.

@en

type

label

Efficacy of early treatment with infliximab in pediatric Crohn's disease.

@ast

Efficacy of early treatment with infliximab in pediatric Crohn's disease.

@en

prefLabel

Efficacy of early treatment with infliximab in pediatric Crohn's disease.

@ast

Efficacy of early treatment with infliximab in pediatric Crohn's disease.

@en

P1433

Q33782089-AA9B69B4-4682-4073-AC37-F9379A5387DF

P1476

Q33782089-3F1ACC15-92EF-43C5-94A5-2DF96B322F65

P2093

Q33782089-2736F21E-B0A7-4977-83C7-DC57FFAD8B92

Q33782089-2B221DAB-57C5-4EBE-947E-35806AD5B9BA

Q33782089-A67E9D99-F9EF-4A4B-8055-2254029B7111

Q33782089-C463DADD-A7CD-4472-B23F-BF93B0EF721A

Q33782089-D786AB97-B015-4CEF-850D-F315976D38DB

Q33782089-EF55B41B-0BAA-4A6C-A714-EBD651C7CFCC

P2860

Q33782089-1BEEE712-AD31-4758-B1D9-642C86DE2679

Q33782089-212A8119-B738-41B9-8B39-73ECAA140929

Q33782089-378BD5D0-339A-4A66-B149-21417B043A29

Q33782089-385F2186-4DF6-4CEC-B91F-DA377589F4A2

Q33782089-3D9EA807-51E2-445B-AA33-3E6F68C36161

Q33782089-4DB346E2-BF53-4823-9074-9AC553B0F5D0

Q33782089-534B4ACA-1294-4804-9DAD-55622BC703EF

Q33782089-61F2354A-0055-4D8B-A270-D90425414B80

Q33782089-62E68495-A713-4209-BAC5-6423CDA6720E

Q33782089-6C6F0C50-48B3-4966-961B-6F23740C3B30

P304

Q33782089-09D1CF60-CB66-4946-B7CD-3BF09F4CCC14

P31

Q33782089-FD7DD3AA-C309-4507-A53E-62D5CA2B7726

P356

Q33782089-DBBAAD72-8B6F-4A86-80DA-C7D121ECB2CE

P407

Q33782089-8C5419FB-4FA9-4D01-B6F4-E0DF86113436

P433

Q33782089-2B8911A5-6540-454F-AB79-807D16750A45

P478

Q33782089-2CE277BC-91C1-4BC3-9143-3A4A58B0D99E

P50

Q33782089-11B183B3-726A-49FC-AEC7-66A58628E631

P577

Q33782089-23401D48-5603-4F7B-8EF8-9258C2F8E40C

P5875

Q33782089-C917EA11-0618-45C5-91F7-353C7F3152FF

P698

Q33782089-13E2F773-A280-4CAD-A880-D62F977C2C36

P921

Q33782089-7A01833C-7663-4E15-A67C-9EF14EC13BE7

P932

Q33782089-EECDEBA5-E5B4-4383-B808-534E2E0378AE

P356

WJG.V16.I14.1776

P1433

World Journal of Gastroenterology

P1476

Efficacy of early treatment with infliximab in pediatric Crohn's disease

@en

P2093

Hae Jeong Lee

http://www.w3.org/2001/XMLSchema#string

Hye Jin Lee

http://www.w3.org/2001/XMLSchema#string

Jee Hyun Lee

http://www.w3.org/2001/XMLSchema#string

Ji Hyuk Lee

http://www.w3.org/2001/XMLSchema#string

Jong Seung Lee

http://www.w3.org/2001/XMLSchema#string

Yon Ho Choe

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor necrosis factor-alpha antibody for maintenance of remission in Crohn's disease

Tumor necrosis factor-alpha antibody for induction of remission in Crohn's disease

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Unravelling the pathogenesis of inflammatory bowel disease

Use of infliximab in the treatment of Crohn's disease in children and adolescents.

Lack of common NOD2 variants in Japanese patients with Crohn's disease.

Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease.

Review article: the limitations of corticosteroid therapy in Crohn's disease.

Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study.

Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease.

P304

1776-1781

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V16.I14.1776

http://www.w3.org/2001/XMLSchema#string

P407

P433

14

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

43081264

http://www.w3.org/2001/XMLSchema#string

P698

20380012

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease

P932

2852828

http://www.w3.org/2001/XMLSchema#string